Protective Effects of Paricalcitol on Peritoneal Remodeling during Peritoneal Dialysis

Table 2

Effect of paricalcitol on mineral homeostasis.

Treatment	Five weeks				Seven weeks
Group	I	II	III	IV	I	II	III	IV
1.25 vitamin D3 (pmol/L)	436.0	342.0	564.0	310.5	255.5	33.5	384	42
IQR	[352.8–519.3]	[256.0–427.0]	[427.5–673.5]	[288.0–365.3]	[225–279]	[30.8–36]	[330.8–456.8]	[39–45]
25 vitamin D3	No data	No data	No data	No data	63	39	75.5	52
IQR					[59.5–70.8]	[37.8–40.5]	[69.3–79.8]	[51–54]
Phosphate (mmol/L)	3.4	4.6	3.3	3.2	3.0	3.4	3.6	4.1
IQR	[2.7–4.1]	[4.0–4.7]	[3.2–3.4]	[2.8–3.6]	[3.0–3.2]	[3.1–3.5]	[3.6–4.5]	[3.6–5.4]
Calcium (mmol/L)	3.6	3.6	3.5	3.4	3.2	3.1	3.4	3.4
IQR	[3.6–3.8]	[3.4–3.8]	[3.2–3.5]	[3.3–3.5]	[3.1–3.3]	[3.2–3.0]	[3.3–3.6]	[3.4–3.2]

All data presented as median and interquartiles.
compared to group I; compared to group III.